In the event of an inadvertent temperature excursion the following data may be used:
Actrapid vial: The products are stable when exposed to temperatures <25°C for 4 weeks (40 units/mL) or 6 weeks (100 units/mL).
Actrapid Penfill, InnoLet, FlexPen: The products are stable when exposed to temperatures <30°C for 6 weeks.

Please refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

In the event of an inadvertent temperature excursion the following data may be used:
The cartridges are stable when exposed to temperatures <30°C for 28 days. Do not return to the fridge.
The vials are stable when exposed to temperatures <30°C for 28 days.
Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Contact Eli Lilly in all other cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company details.